Keymed Biosciences (HKSE:02162) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Price-to-Operating-Cash-Flow?

As of today (2025-06-04), Keymed Biosciences's share price is HK$44.85. Keymed Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-3.23. Hence, Keymed Biosciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Keymed Biosciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:02162's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.27
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Keymed Biosciences's Cash Flow from Operations per share for the six months ended in Dec. 2024 was HK$-1.72. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-3.23.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -25.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -53.10% per year.

During the past 6 years, Keymed Biosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was -25.30% per year. The lowest was -82.90% per year. And the median was -34.50% per year.

Keymed Biosciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Keymed Biosciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Price-to-Operating-Cash-Flow Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Keymed Biosciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Keymed Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keymed Biosciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keymed Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Keymed Biosciences's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Keymed Biosciences Price-to-Operating-Cash-Flow Calculation

Keymed Biosciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	44.85	/	-3.23
	=

Keymed Biosciences's Share Price of today is HK$44.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Keymed Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-3.23.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Keymed Biosciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.

Executives

Chen Bo	2201 Interest of corporation controlled by you
Eagle Hero Management Limited	2101 Beneficial owner
Trident Trust Company (hk) Limited	2301 Trustee
Moonshot Holdings Limited	2101 Beneficial owner
Hh Kny Holdings Limited
Hillhouse Investment Management, Ltd.
Boyu Capital Group Holdings Ltd
Xyxy Holdings Ltd.
Tong Xiaomeng

Keymed Biosciences Headlines

No Headlines